Literature DB >> 11335933

Influence of oxidation and crosslinking on oxygen binding properties of mouse erythrocytes.

L A Lotero1, J A Jordán, R M López, A I García-Pérez, J C Diez.   

Abstract

Different chemical treatments for mouse erythrocyte modification has been used. Oxidation treatments with Ascorbate/Fe(3+), a system able to react with intracellular proteins, produced a displacement of the O(2) binding equilibrium curve to a higher affinity behaviour with loss of the haemoglobin cooperativity for oxygen binding. Incubation of mouse erythrocytes with diamide showed that at low reagent concentration (0.8 mM) no modification on oxygen binding equilibrium curves was observed. At higher reagent concentration (2.0 mM), an increased affinity and a disappearance of the cooperative behaviour can be observed. Additionally, crosslinking reactions on mouse erythrocytes with band 3 crosslinkers seemed to affect oxygen binding properties when used at a crosslinker concentration of 5 mM. Oxyhaemoglobin levels in crosslinked and diamide-treated erythrocytes are similar to those found in control cells. In contrast, ascorbate/Fe(3+) treatments produced an increment in the proportion of methaemoglobin, decreasing the oxyhaemoglobin levels in these oxidized erythrocytes. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11335933     DOI: 10.1002/cbf.901

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  2 in total

1.  Diamide decreases deformability of rabbit erythrocytes and attenuates low oxygen tension-induced ATP release.

Authors:  Meera Sridharan; Randy S Sprague; Shaquria P Adderley; Elizabeth A Bowles; Mary L Ellsworth; Alan H Stephenson
Journal:  Exp Biol Med (Maywood)       Date:  2010-08-03

2.  The Rho kinase inhibitor Y-27632 increases erythrocyte deformability and low oxygen tension-induced ATP release.

Authors:  K M Thuet; E A Bowles; M L Ellsworth; R S Sprague; A H Stephenson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-02       Impact factor: 4.733

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.